1 / 7

Global Pharmaceutical

Innovations have contributed to the availability of a range of new treatments for diseases resulting in improvement in the length and quality of life and reduced disease burden for individuals and society. However, the need for innovative therapies for unmet needs /challenging diseases continues to grow, accelerating the pace of drug development directly or through partnership/ in-licensing

guest100843
Download Presentation

Global Pharmaceutical

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Pharmaceutical & Biotechnology Outlook 2014: Rising Stars One-Stop Shop for Business Information

  2. Summary Innovations have contributed to the availability of a range of new treatments for diseases resulting in improvement in the length and quality of life and reduced disease burden for individuals and society.  However, the need for innovative therapies for unmet needs /challenging diseases continues to grow, accelerating the pace of drug development directly or through partnership/ in-licensing. We expect innovation and improved drugs therapies through novel target discovery and technology platforms to continue to flow from the backyards of small research focused companies (Rising Stars, RS – non-profitable biotech companies) in coming years.  

  3. Approval of new drugs, successful launches, maturing pipeline sustained the growth trajectory of biotech companies resulting in successful IPOs. We expect the optimism to percolate further into companies with novel technology platforms and targets. For more details on the trend in drug approvals, upcoming milestones and M&A in coming years please see Global Pharmaceutical and Biotechnology Outlook 2014 :Rising Stars

  4. Table Of Contents • Ablynx- Nanobodies – Turnarond on the Horizon! • Ambit Biosciences- Quizartinib in RR-AML = Delayed but not Dead! • Basilea- “Drugs for Bad Bugs” Isavuconazole– Watch out for ACTIVE and VITAL • Cempra (CEMP) • Endocyte- • Enanata- The Party to Continue in 2014 – 2nd in the Oral IFN-free HCV Drug Race • Galapagos- Drug Discovery platform driving robust Partnership –AbbVie, GSK, Janssen, Servier.. • Incyte - INCB39110 – Another JAK-Fruit in INCY's Bucket • ISIS - Beyond KYNAMRO – Targeting Other Niche Indications • Morphosys - MOR103/ MOR202 – Partnering is the Beginning of a New Phase of Growth

  5. Related Reports • Partnerships, Licensing, Investments and M&A Deals and Trends for January 2014 in Pharmaceuticals • The Chinese Pharmaceuticals Market to 2024 • Kazakhstan Pharmaceuticals and Healthcare Report • Estonia Pharmaceuticals and Healthcare Report • Canada Pharmaceuticals and Healthcare Report

  6. Custom Research Incase the reports don’t match your requirement then we can do a Custom Research for you. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us at a unique position to take up Custom Research demands of yours. We provide the specifications of the custom research job to a dedicated team comprising of researchers, analysts and industry experts, who have close experience and understanding of global markets, competitive landscapes, various business models, market shares, drivers, restraints and benchmarks.

  7. To know more :Global Pharmaceutical & Biotechnology Outlook 2014: Rising Stars Contact Us:-Call India: +91-22-27810772/73 Call USA/Canada (Toll Free): 1-866-279-8368 Email id : info@bharatbook.com

More Related